KFA Browser > Zanamivir 5 mg Serbuk Inhalasi (RELENZA)

Zanamivir 5 mg Serbuk Inhalasi (RELENZA)

  1. General Information
  2. Sales Information
  3. Anatomical Therapeutic Chemical Group
  4. Identifier Reference
  5. Actual Medicinal Product (POAK)
  6. Ingredients
  7. Product Hierarchy
KFA Code (PV) 93015066
Type Obat
Unit of Measure (UCUM) milligram
Smallest Logistic Unit Canister
Dosage Form Serbuk Inhaler
Drug Classification Obat Keras
Route Administration Inhalasi (dihirup)
NIE BPOM DKI1082002067A1
Trade Name RELENZA
Manufacturer GLAXOSMITHKLINE AUSTRALIA PTY LTD
Registrar SMITHKLINE BEECHAM PHARMACEUTICALS
Chemical Substance (INN) J05AH01 - Zanamivir
Anatomical Main Group J - ANTIINFECTIVES FOR SYSTEMIC USE
Therapectic Subgroup J05 - ANTIVIRALS FOR SYSTEMIC USE
Pharmacological Subgroup J05A - DIRECT ACTING ANTIVIRALS
Chemical Subgroup J05AH - Neuraminidase inhibitors
Alternative Name (USAN) zanamivir
NIE BPOM DKI1082002067A1 - RELENZA
NIE BPOM DKI1082002067A1 - RELENZA
Kamus Farmalkes (KFA – IHS) 93015066 - Zanamivir 5 mg Serbuk Inhalasi
Name Display Name Dosage

ZANAMIVIR

ZANAMIVIR

5 mg
KFA Code (PV) Pack Type Estimated Pack Price (IDR)
94020276 Dus isi 1 -

Product Hierarchy